These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11117292)

  • 21. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
    Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
    Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppressive effect of regucalcin on cell differentiation and mineralization in osteoblastic MC3T3-E1 cells.
    Yamaguchi M; Kobayashi M; Uchiyama S
    J Cell Biochem; 2005 Oct; 96(3):543-54. PubMed ID: 16052480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phytocomponent p-hydroxycinnamic acid stimulates mineralization in osteoblastic MC3T3-E1 cells.
    Yamaguchi M; Lai YL; Uchiyama S; Nakagawa T
    Int J Mol Med; 2008 Sep; 22(3):287-91. PubMed ID: 18698486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
    Hecht DW; Osmolski JR
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Sörgel F; Weidner W; Naber KG
    Int J Antimicrob Agents; 2006 Dec; 28(6):551-9. PubMed ID: 17101261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro.
    Hausser HJ; Brenner RE
    J Cell Biochem; 2004 Apr; 91(5):1062-73. PubMed ID: 15034940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.
    Join-Lambert OF; Michéa-Hamzehpour M; Köhler T; Chau F; Faurisson F; Dautrey S; Vissuzaine C; Carbon C; Pechère J
    Antimicrob Agents Chemother; 2001 Feb; 45(2):571-6. PubMed ID: 11158756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro antimalarial activity of trovafloxacin, a fourth-generation fluoroquinolone.
    Hamzah J; Skinner-Adams T; Davis TM
    Acta Trop; 2000 Jan; 74(1):39-42. PubMed ID: 10643906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effects of aminoglycosides and fluoroquinolones on keratocytes.
    Seitz B; Hayashi S; Wee WR; LaBree L; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):656-65. PubMed ID: 8595966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities.
    Firsov AA; Vostrov SN; Shevchenko AA; Portnoy YA; Zinner SH
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2841-7. PubMed ID: 9797213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of trovafloxacin in an animal model.
    Thadepalli H; Salem F; Chuah SK; Gollapudi S
    In Vivo; 2005; 19(1):269-76. PubMed ID: 15796186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of naringin on proliferation, differentiation and matrix mineralization of MC3T3-E1 cells].
    Ding P; Tang Q; Chen L
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(13):1712-6. PubMed ID: 19873788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
    Nakano Y; Addison WN; Kaartinen MT
    Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of osteoblast Phex expression by PTH.
    Alos N; Ecarot B
    Bone; 2005 Oct; 37(4):589-98. PubMed ID: 16084134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
    Ernst ME; Ernst EJ; Klepser ME
    Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.